The ganglioside GM(3) is raised in the sera and tissue of patients with bladder tumours

  • Authors:
    • M Slevin
    • B Costello
    • S Kumar
    • J Gaffney
  • View Affiliations

  • Published online on: February 1, 1996     https://doi.org/10.3892/ijo.8.2.271
  • Pages: 271-274
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

An extraction procedure was developed which allowed the quantification of gangliosides from small volumes of sera (0.5 cm(3)) and samples of tissue (10 mg wet weight) from subjects with bladder cancer and from controls. The gangliosides were identified by high performance thin layer chromatography and mass spectrometry. In all samples the major ganglioside was GM(3) and amounts were elevated in both tissue and sera derived from tumour patients. The total lipid-bound sialic acid was greater in tumour tissue than in healthy bladder but was below the level of detection in all sera. We suggest that serum GM(3) may be of prognostic value in bladder cancer.

Related Articles

Journal Cover

February 1996
Volume 8 Issue 2

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Slevin M, Costello B, Kumar S and Gaffney J: The ganglioside GM(3) is raised in the sera and tissue of patients with bladder tumours. Int J Oncol 8: 271-274, 1996
APA
Slevin, M., Costello, B., Kumar, S., & Gaffney, J. (1996). The ganglioside GM(3) is raised in the sera and tissue of patients with bladder tumours. International Journal of Oncology, 8, 271-274. https://doi.org/10.3892/ijo.8.2.271
MLA
Slevin, M., Costello, B., Kumar, S., Gaffney, J."The ganglioside GM(3) is raised in the sera and tissue of patients with bladder tumours". International Journal of Oncology 8.2 (1996): 271-274.
Chicago
Slevin, M., Costello, B., Kumar, S., Gaffney, J."The ganglioside GM(3) is raised in the sera and tissue of patients with bladder tumours". International Journal of Oncology 8, no. 2 (1996): 271-274. https://doi.org/10.3892/ijo.8.2.271